Objectives: The plasma apolipoprotein B (apo B) concentrations have been co
nsidered to be a more accurate representation of atherogenic particles and
it has been proposed that the formula LDL-C (mmol/L) = 0.41TC - 0.32TG + 1.
70apo B - 0.27 is reliable for the estimation of LDL-C (Clin Chem 1997; 43:
308-15). We undertook the present study to investigate the reliability of
this formula in a large number of hyperlipidemic patients.
Design and methods: 1) The Friedewald formula (LDL-F) and the apo B-based f
ormula (LDL-B) were compared with the P-quantification reference procedure
in 130 individuals with a wide range of total cholesterol CTC) and triglyce
ride CTG) levels, and 2) the LDL-C levels obtained by the Friedewald formul
a were compared with those calculated by the apo B-based formula in 1010 in
dividuals attending our outpatient lipid clinic.
Results: The LDL-F and the LDL-B formulae for LDL-C estimation were found t
o be in good agreement with the beta -quantification (r = 0.96 and 0.97, re
spectively). The bias of each method plotted as a function of TG (up to 4.5
2 mmol/L) was found positive for the LDL-F, whereas the LDL-B was independe
nt of the concentrations of TG. When a large number of individuals were exa
mined, a good correlation between the two equations was found (n = 1010, r
= 0.98). The difference between the two methods was not correlated with ser
um TG levels. However, it was correlated to serum TC, and apo B levels.
Conclusions: The LDL-B formula is a more reliable and accurate method than
the LDL-F formula, especially at To levels >2.26 mmol/L, although it undere
stimates LDL-C concentrations. Furthermore, this equation can be used in hy
pertriglyceridemic patients CTG >4.52 mmol/L) in whom the Friedewald equati
on is inaccurate. Copyright (C) 2000 The Canadian Society of Clinical Chemi
sts.